CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
DUBAI,UAE,Feb. 14,2025-- Wearing a "Tech Support"-printed T-shirt,Elon Musk virtually took to the stage on the final day of the World Governments Summit in a live discussion with H.E. Omar S
SANTA CLARA,Calif.,Feb. 14,2025-- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading cloud platform service provider,today announced that it will report
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite
